This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 14-20 January 2024 and includes updates on avian influenza, SARS-CoV-2 variant classification, an overview of respiratory viruses in the EU/EEA, mpox, measles, and Infant formula for medical purposes recalled due to possible contamination with Cronobacter sakazakii.
This generic protocol for ECDC studies describes the design and methods for a prospective multi-country cohort study of hospital-based healthcare workers (HCWs) to evaluate the effectiveness of COVID-19 vaccine in preventing laboratory-confirmed SARS-CoV-2 infection.
OJ/2023/DPR/26575 - External quality assessment of antimicrobial susceptibility testing for Salmonella and Campylobacter - Lot 1: AST EQA for Salmonella enterica - Lot 2: AST EQA for Campylobacter spp.
Ref.:OJ/2023/DPR/26575 - ECDC/2024/OP/0004 | Media type:call for tender
On 18 January 2023, Dr. Andrea Ammon visited Chisinau, Moldova, accompanied by representatives from the European and International Cooperation Section.
Influenza is a disease of public health importance due to the substantial seasonal morbidity and mortality and the high pandemic potential of its aetiologic agents, influenza viruses.